All Type of News
ProteomeTech acquires approval of IgE content diagnostic kit for first time in Korea
ProteomeTech(CEO Kook-Jin Lim) announced sales and manufacturing approval of the real-time monitoring of human IgE content ‘ImmuneCheck IgE’ from the Ministry of Food and Drug Safety on 8 August.
‘ImmuneCheck IgE,’ a...
Green Cross Cell’s Immune Cell-LC designated as orphan drug for brain tumor from FDA
Green Cross Cell(Duk-Joo Lee), a cell therapy company, announced on the 17th that their ‘Immune Cell-LC’ was designated as orphan drug from the U.S. FDA on the 17th.
Immune Cell-LC acquired approval as an anticancer ...
MFDS approves 2 AI-based medical devices developed in Korea
The Ministry of Food and Drug Safety announced approval of the AI-powered medical image analysis software ‘Lunit INSIGHT’ and the AI-based stroke diagnostic supporting system ‘JBS-01K’ developed by ‘Lunit’ and ‘JLK IN...
Huons Jecheon Factory being selected for ‘Demo Project for Smart Factories’ for first time as pharma
Huons, a subsidiary of Huons Global(CEO Sung-Tae Yoon & Wan-Sup Kim), announced they were selected for the ‘Demo Project for Establishment of Smart Factories’ for the first time as a pharmaceutical company.
Located i...
KPBMA searching for contact manufacturing companies for 12 essential medicines
The association will find contract manufacturing companies for 12 essential medicines which require stably supply.
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA) gave a notice of the ‘Cooper...
AbbVie Korea recruits Executive Director Young-Shin Park as new general manager for immunology business
AbbVie Korea(CEO Hong-Ki Ryu) recruited Executive Director Young-Shin Park(47) as a general manager of its immunology business.
Executive Director Young-Shin Park generally managed the pharmaceutical department at Al...
LG Chem signs co-research agreement to discover new substance candidates with Chinese ‘HitGen’
In order to accelerate the speed of discovering new drug candidates, LG Chem will actively cooperate with Chinese biotechnology companies.
On the 17th, LG Chem signed a co-research agreement with Chinese HitGen which...
‘3-month license suspension’ for providing narcotics without prescription
A new revision bill will be established to the Medical Law to revise regulations, such as 3-month license suspension for administering and providing narcotics and antipsychotics without doctors’ prescription.
The re...
Listed pharmas earned KRW 68 for selling products worth of KRW 1,000 in the first half
Listed pharmaceutical companies’ profitability is getting weaker and weaker with a decrease in operating profits.
Yakup Shinmoon(www.yakup.com) analyzed KOSPI and KOSDAQ listed pharmaceutical companies’ 2018 1st half...
When they will decide on ‘vacant’ position for ‘KPBMA’?
The industry is paying attention to when the next chairman of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA) will be appointed. This is because it already has been the scheduled 6 months sinc...
